Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic.
Cancer Discov
; 11(6): 1330-1335, 2021 06.
Article
in English
| MEDLINE | ID: covidwho-1166606
ABSTRACT
Patients with cancer have been disproportionally affected by the COVID-19 pandemic, with high rates of severe outcomes and death. Similarly, treatment decisions in this vulnerable population have been altered to a major degree during the past year, with significant disruption of care reported. Although complex, therapeutic choices in patients with cancer in times of COVID-19 are critical, as they may save thousands of lives. A mounting body of evidence, in addition to clear recommendations by multiple international societies, can help oncologists decide appropriately the necessity to administer antineoplastic regimens, helping to avoid a surge in cancer-related deaths in the upcoming months.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Cancer Discov
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS